Vista Pharma.

{
  "main_header": {
    "sid": 384463,
    "name": "Vista Pharma.",
    "stock_name": "Vista Pharma.",
    "full_name": "Vista Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/vista-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "8.42",
    "chg": 0.04,
    "chgp": "0.48%",
    "dir": 1,
    "prev_price": "8.38",
    "mcapval": "52.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524711,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE427C01021",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": "2.29 k",
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vista-pharma-384463-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Vista Pharmaceuticals Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vista-pharmaceuticals-ltd-fallingrising-3779250",
        "imagepath": "",
        "date": "2026-01-03 01:39:22",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Vista Pharmaceuticals Ltd’s share price has fallen by ₹0.16 on 02-Jan, marking a near 2% drop in a single session. This decline is part of a wider negative trend, with the stock losing 6.76% over the past week, in stark contrast to the Sensex’s modest gain of 0.85% during the same period. Over the last month, the stock has declined by 2.79%, while the benchmark index has advanced by 0.73%. Even year-to-date, Vista Pharma’s shares have slipped 1.72%, whereas the Sensex has recorded a 0.64% increase. These figures highlight the stock’s consistent underperformance against the broader market.</p>\n<p><strong>Long-Term Underperformance Compared to Benchmarks</strong></p>\n<p>Examining the longer-term performance reveals a more concerning pict..."
      },
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-3769687",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VistaPharmaceut_mojoScore_3769687.png",
        "date": "2025-12-25 15:12:53",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 Jul 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial data presented here are based on the company’s current position as of 25 December 2025, providing investors with the latest insights into its performance and prospects."
      },
      {
        "title": "Vista Pharma. Sees Revision in Market Assessment Amid Challenging Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharma-downgraded-to-strong-sell-amid-deteriorating-fundamentals-and-bearish-technicals-3750096",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VistaPharma_mojoScore_3750096.png",
        "date": "2025-12-07 10:10:21",
        "description": "Vista Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational performance. The recent assessment highlights concerns across multiple parameters including quality, valuation, financial trends, and technical outlook, underscoring the stock's current position within a difficult market environment."
      },
      {
        "title": "Why is Vista Pharma. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vista-pharma-fallingrising-3715985",
        "imagepath": "",
        "date": "2025-11-19 21:49:42",
        "description": "As of 19-Nov, Vista Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 9.18, which represents a rise of 1.53 or 20.0%. Today, the stock has outperformed its sector by 19.93% and has shown a trend reversal after two consecutive days of decline. It opened with a significant gain of 9.54% and reached an intraday high of Rs 9.18. However, despite this positive movement, the stock has been trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 25.71% compared to the 5-day average, indicating a potential concern regarding sustained interest in the stock.\n\nIn the broader market context, Vista Pharmaceuticals has underperformed compared to the Sensex over various periods, including a 3-year return of +19.22% against the Sensex's +38.15%. In the short term, the st..."
      },
      {
        "title": "Vista Pharmaceuticals Hits Upper Circuit Amidst Extraordinary Buying Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vista-pharmaceuticals-hits-upper-circuit-amidst-unprecedented-buying-interest-3715279",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VistaPharmaceut_only_buyers_3715279.png",
        "date": "2025-11-19 12:05:13",
        "description": "Vista Pharmaceuticals Ltd witnessed an exceptional surge in buying interest on 19 Nov 2025, hitting the upper circuit with only buy orders in the queue. The stock recorded a remarkable 20.00% gain in a single trading session, significantly outperforming the Sensex’s modest 0.33% rise, signalling a potential multi-day circuit scenario driven by extraordinary demand and absence of sellers."
      },
      {
        "title": "Why is Vista Pharma. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vista-pharma-fallingrising-3712836",
        "imagepath": "",
        "date": "2025-11-18 21:47:08",
        "description": "As of 18-Nov, Vista Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs. 8.00, which represents a decrease of Rs. 0.39 or 4.65%. The stock has hit a new 52-week low of Rs. 7.63 today and has underperformed its sector by 4.03%. It has been on a downward trend, losing 15.07% over the last two days. Additionally, the stock has shown poor performance over various time frames, with a year-to-date decline of 32.09% and a one-year drop of 33.88%. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Although there has been a significant increase in investor participation, with delivery volume rising by 2223.84% against the 5-day average, the overall sentiment remains negative.\n\nIn the broader market context, Vista Pharmaceuticals' performance has been notably worse than the benchmark Sensex, which has gained 0..."
      },
      {
        "title": "Vista Pharmaceuticals Falls to 52-Week Low of Rs.7.63 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vista-pharmaceuticals-falls-to-52-week-low-amidst-continued-downtrend-3712184",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VistaPharmaceut_priceRelatedfactors_3712184.png",
        "date": "2025-11-18 15:46:47",
        "description": "Vista Pharmaceuticals has reached a new 52-week low of Rs.7.63 today, marking a significant decline in its stock price amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance and valuation metrics."
      },
      {
        "title": "Why is Vista Pharma. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vista-pharma-fallingrising-3708170",
        "imagepath": "",
        "date": "2025-11-17 21:40:00",
        "description": "As of 17-Nov, Vista Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs. 8.39, which reflects a decrease of Rs. 1.03 or 10.93%. The stock has hit a new 52-week low of Rs. 8 today and has underperformed its sector by 11.21%. Although it opened with a gain of 3.4% and reached an intraday high of Rs. 9.9, it also saw a significant drop to an intraday low of Rs. 8, indicating high volatility with an intraday fluctuation of 10.61%. The stock has consistently underperformed over various periods, showing a year-to-date decline of 28.78% and a one-year drop of 31.51%. Additionally, it is trading below all key moving averages, which suggests a bearish trend. The delivery volume has increased significantly, indicating rising investor participation, but this has not translated into positive price movement.\n\nBroader Market Context: In comparison to the benchmark Sensex, which has shown pos..."
      },
      {
        "title": "Vista Pharmaceuticals Hits New 52-Week Low at Rs. 8 Amid Market Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vista-pharmaceuticals-hits-new-52-week-low-at-rs-8-amid-market-struggles-3707026",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VistaPharmaceut_priceRelatedfactors_3707026.png",
        "date": "2025-11-17 10:43:44",
        "description": "Vista Pharmaceuticals has reached a new 52-week low of Rs. 8, reflecting a significant decline in its stock performance. The company has faced a 28.49% drop over the past year, alongside ongoing financial challenges, including operating losses and a negative EBIT to Interest ratio, raising concerns about its market position."
      }
    ],
    "total": 5699,
    "sid": "384463",
    "stock_news_url": "https://www.marketsmojo.com/news/vista-pharmaceuticals-384463"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "13-Jan-2026",
      "details": "Compliance - Certificate under Reg 74(5) of SEBI (DP) Regulations",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "30-Dec-2025",
      "details": "Closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Un Audited Financials Results For The Quarter And Half Year Ended 30.09.2025",
      "datetime": "13-Nov-2025",
      "details": "Un audited Financials Results for the quarter and half year ended 30.09.2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Vista Pharmaceuticals Ltd falling/rising?

2026-01-03 01:39:22

Recent Price Movement and Market Context

Vista Pharmaceuticals Ltd’s share price has fallen by ₹0.16 on 02-Jan, marking a near 2% drop in a single session. This decline is part of a wider negative trend, with the stock losing 6.76% over the past week, in stark contrast to the Sensex’s modest gain of 0.85% during the same period. Over the last month, the stock has declined by 2.79%, while the benchmark index has advanced by 0.73%. Even year-to-date, Vista Pharma’s shares have slipped 1.72%, whereas the Sensex has recorded a 0.64% increase. These figures highlight the stock’s consistent underperformance against the broader market.

Long-Term Underperformance Compared to Benchmarks

Examining the longer-term performance reveals a more concerning pict...

Read full news article

Vista Pharmaceuticals Ltd is Rated Strong Sell

2025-12-25 15:12:53

Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 Jul 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial data presented here are based on the company’s current position as of 25 December 2025, providing investors with the latest insights into its performance and prospects.

Read full news article

Vista Pharma. Sees Revision in Market Assessment Amid Challenging Financial Trends

2025-12-07 10:10:21

Vista Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational performance. The recent assessment highlights concerns across multiple parameters including quality, valuation, financial trends, and technical outlook, underscoring the stock's current position within a difficult market environment.

Read full news article

Why is Vista Pharma. falling/rising?

2025-11-19 21:49:42

As of 19-Nov, Vista Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 9.18, which represents a rise of 1.53 or 20.0%. Today, the stock has outperformed its sector by 19.93% and has shown a trend reversal after two consecutive days of decline. It opened with a significant gain of 9.54% and reached an intraday high of Rs 9.18. However, despite this positive movement, the stock has been trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 25.71% compared to the 5-day average, indicating a potential concern regarding sustained interest in the stock. In the broader market context, Vista Pharmaceuticals has underperformed compared to the Sensex over various periods, including a 3-year return of +19.22% against the Sensex's +38.15%. In the short term, the st...

Read full news article

Vista Pharmaceuticals Hits Upper Circuit Amidst Extraordinary Buying Interest

2025-11-19 12:05:13

Vista Pharmaceuticals Ltd witnessed an exceptional surge in buying interest on 19 Nov 2025, hitting the upper circuit with only buy orders in the queue. The stock recorded a remarkable 20.00% gain in a single trading session, significantly outperforming the Sensex’s modest 0.33% rise, signalling a potential multi-day circuit scenario driven by extraordinary demand and absence of sellers.

Read full news article

Why is Vista Pharma. falling/rising?

2025-11-18 21:47:08

As of 18-Nov, Vista Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs. 8.00, which represents a decrease of Rs. 0.39 or 4.65%. The stock has hit a new 52-week low of Rs. 7.63 today and has underperformed its sector by 4.03%. It has been on a downward trend, losing 15.07% over the last two days. Additionally, the stock has shown poor performance over various time frames, with a year-to-date decline of 32.09% and a one-year drop of 33.88%. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Although there has been a significant increase in investor participation, with delivery volume rising by 2223.84% against the 5-day average, the overall sentiment remains negative. In the broader market context, Vista Pharmaceuticals' performance has been notably worse than the benchmark Sensex, which has gained 0...

Read full news article

Vista Pharmaceuticals Falls to 52-Week Low of Rs.7.63 Amidst Continued Downtrend

2025-11-18 15:46:47

Vista Pharmaceuticals has reached a new 52-week low of Rs.7.63 today, marking a significant decline in its stock price amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance and valuation metrics.

Read full news article

Why is Vista Pharma. falling/rising?

2025-11-17 21:40:00

As of 17-Nov, Vista Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs. 8.39, which reflects a decrease of Rs. 1.03 or 10.93%. The stock has hit a new 52-week low of Rs. 8 today and has underperformed its sector by 11.21%. Although it opened with a gain of 3.4% and reached an intraday high of Rs. 9.9, it also saw a significant drop to an intraday low of Rs. 8, indicating high volatility with an intraday fluctuation of 10.61%. The stock has consistently underperformed over various periods, showing a year-to-date decline of 28.78% and a one-year drop of 31.51%. Additionally, it is trading below all key moving averages, which suggests a bearish trend. The delivery volume has increased significantly, indicating rising investor participation, but this has not translated into positive price movement. Broader Market Context: In comparison to the benchmark Sensex, which has shown pos...

Read full news article

Vista Pharmaceuticals Hits New 52-Week Low at Rs. 8 Amid Market Struggles

2025-11-17 10:43:44

Vista Pharmaceuticals has reached a new 52-week low of Rs. 8, reflecting a significant decline in its stock performance. The company has faced a 28.49% drop over the past year, alongside ongoing financial challenges, including operating losses and a negative EBIT to Interest ratio, raising concerns about its market position.

Read full news article

View All News